NR4A1 and triple-negative breast carcinoma: In these studies, luminal subtypes were observed more frequently in the NP group with 77% of tumors showing hormone receptor positivity, whereas patients with HER2 positive and triple-negative breast cancer (TNBC) were more common in the TR group seen in 53% of the whole patient group [3, 17].